Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes

Diabetes Care. 2011 Apr;34(4):789-94. doi: 10.2337/dc11-0064.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bromocriptine / administration & dosage
  • Bromocriptine / pharmacokinetics*
  • Bromocriptine / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / pharmacokinetics
  • Dopamine Agonists / therapeutic use*
  • Humans

Substances

  • Dopamine Agonists
  • Bromocriptine